KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Tenet Healthcare (THC) over the last 17 years, with Q4 2025 value amounting to $731.0 million.

  • Tenet Healthcare's Cash from Operations rose 32084.59% to $731.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.5 billion, marking a year-over-year increase of 7293.6%. This contributed to the annual value of $3.5 billion for FY2025, which is 7293.6% up from last year.
  • As of Q4 2025, Tenet Healthcare's Cash from Operations stood at $731.0 million, which was up 32084.59% from $1.1 billion recorded in Q3 2025.
  • In the past 5 years, Tenet Healthcare's Cash from Operations registered a high of $1.1 billion during Q3 2025, and its lowest value of -$331.0 million during Q4 2024.
  • Over the past 5 years, Tenet Healthcare's median Cash from Operations value was $518.5 million (recorded in 2021), while the average stood at $530.6 million.
  • As far as peak fluctuations go, Tenet Healthcare's Cash from Operations skyrocketed by 40252.1% in 2023, and later plummeted by 14016.99% in 2024.
  • Tenet Healthcare's Cash from Operations (Quarter) stood at $357.0 million in 2021, then increased by 17.93% to $421.0 million in 2022, then surged by 95.72% to $824.0 million in 2023, then crashed by 140.17% to -$331.0 million in 2024, then skyrocketed by 320.85% to $731.0 million in 2025.
  • Its last three reported values are $731.0 million in Q4 2025, $1.1 billion for Q3 2025, and $936.0 million during Q2 2025.